286 reports of this reaction
1.7% of all DOFETILIDE reports
#13 most reported adverse reaction
HEART RATE INCREASED is the #13 most commonly reported adverse reaction for DOFETILIDE, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 286 FDA adverse event reports linking DOFETILIDE to HEART RATE INCREASED. This represents approximately 1.7% of all 17,040 adverse event reports for this drug.
Patients taking DOFETILIDE who experience heart rate increased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEART RATE INCREASED is a less commonly reported adverse event for DOFETILIDE, but still significant enough to appear in the safety profile.
In addition to heart rate increased, the following adverse reactions have been reported for DOFETILIDE:
The following drugs have also been linked to heart rate increased in FDA adverse event reports:
HEART RATE INCREASED has been reported as an adverse event in 286 FDA reports for DOFETILIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEART RATE INCREASED accounts for approximately 1.7% of all adverse event reports for DOFETILIDE, making it a notable side effect.
If you experience heart rate increased while taking DOFETILIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.